Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples